Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Congress drug development Drug prices

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6 - 9 days ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - about 2 months ago Adolescent Obesity Tied to Parents' BMI at the Same Age - 3 months ago USPSTF Recommends Behavioral Interventions for Kids With High BMI - 3 months ago Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ - 5 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 7 months ago Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes - 9 months ago Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth - 9 months ago USPSTF Draft Calls for Lifestyle Shift -- Not Meds -- for Kids With Obesity - 9 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 10 months ago Year in Review: Obesity - 10 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 10 months ago Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kids - 11 months ago Over One-Third of Adults in 22 States Have Obesity, CDC Says - 12 months ago
2	Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom science	Daily briefing: What causes obesity? Contentious topic gets an authoritative analysis - 14 days ago
3	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Lilly’s Zepbound slashed risk of developing diabetes - about 1 month ago STAT+: Amgen goes all in on injectable obesity drug as it scraps early-stage pill - 5 months ago STAT+: Positive trial results set up obesity drug Wegovy for use against heart failure - 6 months ago STAT+: Obesity drug Wegovy gets FDA approval to add cardiovascular benefits on its label - 6 months ago More than 1 billion people have obesity, including 159 million young people, study estimates - 7 months ago STAT+: Liver disease MASH is next target for obesity drugs in development - 7 months ago STAT+: What comes after Wegovy? The quest to eradicate obesity - 9 months ago Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch - 9 months ago STAT+: Pfizer to halt development of its twice-daily oral obesity drug, following disappointing trial - 10 months ago STAT+: Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle - 10 months ago AMA urges coverage of obesity treatments as payers balk at costs - 10 months ago STAT+: Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of studies - 11 months ago
4	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	Report: A “Multifaceted Approach” Is Needed To Tackle the Obesity Epidemic - about 1 month ago
5	Amanda Capritto CNET Non-Alcoholic Craft Beer. Low Cal, 0g Sugar. Pacific Northwest craft beernon-alcoholic beverages	Avoid These Weight Loss Habits To Keep Extra Pounds at Bay - about 2 months ago
6	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Race for the Next Ozempic - about 2 months ago
7	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 2 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 7 months ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - 11 months ago STAT+: Pharmalittle: People with obesity harmed by exclusion from studies; Teva sues Colorado over ‘unconstitutional’ program - 11 months ago
8	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: A second Roche obesity drug shows promise in early studies - 2 months ago STAT+: Viking Therapeutics to move its oral obesity drug into Phase 2 study after early success - 6 months ago STAT+: Obesity treatment from Boehringer Ingelheim, Zealand Pharma succeeds in study in liver condition MASH - 7 months ago STAT+: What comes after Wegovy? The quest to eradicate obesity - 9 months ago STAT+: Pfizer to halt development of its twice-daily oral obesity drug, following disappointing trial - 10 months ago
9	Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto ScienceFreelance Writing	Obesity Research is Going to the Dogs - 4 months ago
10	The Conversation Science Alert Science news. Official account. Australia science news	Does Obesity Protect Against Dementia, or Increase Risk? - 5 months ago BMI And Dieting No Longer Taught in Australia. Here's What Kids Will Learn. - 8 months ago

Journalists covering Obesity